Yongkun Li
Overview
Explore the profile of Yongkun Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
AI prediction model for endovascular treatment of vertebrobasilar occlusion with atrial fibrillation
Huang Z, Alexandre A, Pedicelli A, He X, Hong Q, Li Y, et al.
NPJ Digit Med
. 2025 Feb;
8(1):78.
PMID: 39894819
Endovascular treatment (EVT) for vertebrobasilar artery occlusion (VBAO) with atrial fibrillation presents complex clinical challenges. This comprehensive multicenter study of 525 patients across 15 Chinese provinces investigated nuanced predictors beyond...
2.
Xue H, Zeng Y, Zou X, Li Y
Front Neurol
. 2024 Sep;
15:1431727.
PMID: 39329013
Background: The incidence of stroke has increased globally, resulting in medical expenditures and social burdens over the past few decades. We aimed to explore the relationship between systemic immune inflammatory...
3.
Li L, Huang Z, Huang Y, Li Y, Ma X, Li P, et al.
Bioorg Chem
. 2024 Sep;
153:107815.
PMID: 39265523
Immunomodulatory drugs (IMiDs) represented by thalidomide exhibit benefits when combined with other chemotherapeutic drugs for patients with lung cancer, which inspired the exploration of combining pomalidomide with another agent to...
4.
Li D, Wan X, Yun Y, Li Y, Duan W
Curr Genomics
. 2024 Aug;
25(4):261-297.
PMID: 39156728
Background: Understanding organic functions at a molecular level is important for scientists to unveil the disease mechanism and to develop diagnostic or therapeutic methods. Aims: The present study tried to...
5.
Zhang P, Huang Z, Xu Y, Li W, Huang X, Han Z, et al.
J Neurointerv Surg
. 2024 Aug;
PMID: 39137969
Background: Endovascular treatment (EVT) has revolutionized the standard treatment of vertebrobasilar artery occlusion (VBAO) with moderate infarct core, but its effectiveness in patients with a low posterior circulation Acute Stroke...
6.
Qu D, Xi L, Li Y, Yang H, Chen X, Jin W, et al.
J Chromatogr A
. 2024 Jun;
1730:465056.
PMID: 38878742
Chinese bacon is highly esteemed by consumers worldwide due to its unique aroma. The composition of volatile organic compounds (VOCs) varies significantly among different types of Chinese bacon. This study...
7.
Li P, Li Y, Ma X, Li L, Zeng S, Peng Y, et al.
Eur J Med Chem
. 2024 Apr;
271:116416.
PMID: 38657480
Targeting polo-box domain (PBD) small molecule for polo-like kinase 1 (PLK1) inhibition is a viable alternative to target kinase domain (KD), which could avoid pan-selectivity and dose-limiting toxicity of ATP-competitive...
8.
Chen S, Fang S, Zhou Y, Huang Z, Yu S, Chen D, et al.
Cardiovasc Res
. 2024 Mar;
120(10):1191-1201.
PMID: 38546342
Aims: Alteplase is a cornerstone thrombolytic agent in clinical practice but presents a potential bleeding risk. Stroke patients need pre-screening to exclude haemorrhagic stroke before using alteplase. In this study,...
9.
You N, Wu K, Li Y, Zheng L
J Laparoendosc Adv Surg Tech A
. 2024 Jan;
34(3):257-262.
PMID: 38252558
Because of lack of an appropriate surgical approach, laparoscopic surgery in patients with left/right Glisson pedicle involvement is still rarely conducted. This study aimed to discusses the methods of intrahepatic...
10.
Xu Y, Hu Y, Wu G, Niu L, Fang C, Li Y, et al.
Int J Biol Macromol
. 2023 Dec;
257(Pt 2):128618.
PMID: 38070813
Administration of recombinant tPA (rtPA, or trade name Alteplase®) is an FDA-approved therapy for acute ischemic stroke (AIS), but poses the risk of hemorrhagic complications. Recombinant tPA can be rapidly...